Related Experiment Video
Updated: Aug 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity
M Santosham1, I Fayad, M Abu Zikri
1Department of International Health, Center for American Indian and Alaskan Native Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, USA.
Insights
A reduced osmolarity oral rehydration solution (ORS) is more effective than standard WHO-ORS for treating acute diarrhea in children, significantly lowering stool output and vomiting. This new ORS reduces the need for intravenous fluids, improving patient outcomes.
Area of Science:
- Pediatrics
- Gastroenterology
- Public Health
Background:
- Acute diarrhea is a leading cause of childhood mortality globally.
- Oral rehydration solution (ORS) is a cornerstone of diarrhea management.
- Optimizing ORS composition may improve clinical outcomes.
Purpose of the Study:
- To compare the efficacy and safety of a reduced osmolarity ORS (75 mmol/L sodium and glucose) with standard World Health Organization (WHO) ORS.
- To evaluate the impact on stool output, vomiting, and need for intravenous therapy in Egyptian children with acute diarrhea.
Main Methods:
- A randomized controlled trial involving 190 boys aged 1-24 months with acute diarrhea and dehydration.
- Participants received either standard WHO ORS (311 mmol/L) or reduced osmolarity ORS (245 mmol/L).
- Intake, output, and clinical outcomes were monitored over the rehydration and maintenance phases.
Main Results:
- Reduced osmolarity ORS led to a 36% decrease in stool output and significantly lower rates of vomiting during rehydration.
- Children receiving standard WHO ORS had a 7.9-fold increased risk of treatment failure requiring intravenous fluids.
- Mean serum sodium levels were lower but not associated with increased hyponatremia risk in the reduced osmolarity ORS group.
Conclusions:
- Reduced osmolarity ORS demonstrates significant clinical benefits in managing acute noncholera diarrhea in children.
- It effectively reduces stool output, vomiting, and the need for supplemental intravenous therapy.
- These findings support the adoption of reduced osmolarity ORS for improved pediatric diarrhea care.
Objective:
To compare the safety and efficacy of an oral rehydration solution (ORS) containing 75 mmol/L of sodium and glucose each with the standard World Health Organization (WHO) ORS among Egyptian children with acute diarrhea.
Methods:
One hundred ninety boys, aged 1 to 24 months, who were admitted to the hospital with acute diarrhea and signs of dehydration were randomly assigned to receive either standard ORS (311 mmol/L) or a reduced osmolarity ORS (245 mmol/L). Intake and output were measured every 3 hours.
Results:
In the group treated with reduced osmolarity ORS, the mean stool output during the rehydration phase was 36% lower (95% confidence interval, 1%, 100%) than in those treated with WHO ORS. The relative risk of vomiting during the rehydration phase was significantly lower in children treated with reduced osmolarity ORS (relative risk, 2.4; 95% confidence interval, 1.2, 4.8). During the maintenance phase, stool output, mean intake of food and ORS, duration of diarrhea, and weight gain were similar in the treatment groups. The relative risk of treatment failure (need for unscheduled administration of intravenous fluids) was significantly increased in children receiving standard WHO ORS (relative risk, 7.9; 95% confidence interval, 1.1, 60.9). The mean serum sodium concentration at 24 hours was significantly lower in children receiving the reduced osmolarity ORS solution (134 +/- 6 mEq/L) than in children receiving the standard WHO ORS (138 +/- 7 mEq/L) (p < 0.001). The relative risk of the development or worsening of hyponatremia was not increased in children given the reduced osmolarity ORS, and urine output was similar in the treatment groups.
Conclusion:
The reduced osmolarity ORS has beneficial effects on the clinical course of acute diarrhea in children by reducing stool output, and the proportion of children with vomiting during the rehydration phase, and by reducing the need for supplemental intravenous therapy. These results provide support for the use of a reduced osmolarity ORS in children with acute noncholera diarrhea.
Related Concept Videos
What Are Osmoregulation and Excretion?
Blind Procedures
Osmosis and Osmotic Pressure of Solutions
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding
Hyperosmolar Hyperglycemic State

